Salvage chemotherapy after gemcitabine failure in patients with advanced pancreatic cancer : survival benefit in selected patients
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2008 |
|---|---|
| Erschienen: |
2008 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:52 |
|---|---|
| Enthalten in: |
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi - 52(2008), 1 vom: 16. Juli, Seite 59-63 |
| Sprache: |
Koreanisch |
|---|
| Beteiligte Personen: |
Lee, Jae-Lyun [VerfasserIn] |
|---|
| Themen: |
0W860991D6 |
|---|
| Anmerkungen: |
Date Completed 13.01.2009 Date Revised 07.12.2022 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM185128947 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM185128947 | ||
| 003 | DE-627 | ||
| 005 | 20231223171841.0 | ||
| 007 | tu | ||
| 008 | 231223s2008 xx ||||| 00| ||kor c | ||
| 028 | 5 | 2 | |a pubmed24n0617.xml |
| 035 | |a (DE-627)NLM185128947 | ||
| 035 | |a (NLM)19077495 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a kor | ||
| 100 | 1 | |a Lee, Jae-Lyun |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Salvage chemotherapy after gemcitabine failure in patients with advanced pancreatic cancer |b survival benefit in selected patients |
| 264 | 1 | |c 2008 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 13.01.2009 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Angiogenesis Inhibitors |2 NLM | |
| 650 | 7 | |a Antibodies, Monoclonal |2 NLM | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a Antimetabolites, Antineoplastic |2 NLM | |
| 650 | 7 | |a Deoxycytidine |2 NLM | |
| 650 | 7 | |a 0W860991D6 |2 NLM | |
| 650 | 7 | |a Bevacizumab |2 NLM | |
| 650 | 7 | |a 2S9ZZM9Q9V |2 NLM | |
| 650 | 7 | |a Cetuximab |2 NLM | |
| 650 | 7 | |a PQX0D8J21J |2 NLM | |
| 650 | 7 | |a Gemcitabine |2 NLM | |
| 700 | 1 | |a Kim, Yong-Tae |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi |d 2003 |g 52(2008), 1 vom: 16. Juli, Seite 59-63 |w (DE-627)NLM14272808X |x 2233-6869 |7 nnns |
| 773 | 1 | 8 | |g volume:52 |g year:2008 |g number:1 |g day:16 |g month:07 |g pages:59-63 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 52 |j 2008 |e 1 |b 16 |c 07 |h 59-63 | ||